REGN

Regeneron Pharmaceuticals, Inc. (REGN)

Last Price$700.30.6%
Market Cap$75.4B
LTM Free Cash Flow margin
25.3%
5Y avg
30.6%
Biotechnology industry median
(735.0%)
Stock quality & Intrinsic value
7/10
0.4% undervalued

Regeneron Pharmaceuticals, Inc. Free Cash Flow margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
REGN
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Free Cash Flow margin
(53.3%)
31.9%
7.1%
(52.0%)
(44.7%)
(0.7%)
(44.6%)
(9.0%)
20.5%
14.9%
15.9%
20.0%
17.6%
27.0%
25.4%
23.6%
40.6%
36.3%
28.0%
25.8%
REGN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for REGN and see if it's the right time to invest.
Dive in

Regeneron Pharmaceuticals, Inc. (REGN) Free Cash Flow margin comparison analysis

Crunching data... Almost there!

REGN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Regeneron Pharmaceuticals, Inc.'s Free Cash Flow margin?

As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 25.3%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Free Cash Flow margin for Regeneron Pharmaceuticals, Inc. have been 33.4% over the past three years, and 32.2% over the past five years.

2) Is Regeneron Pharmaceuticals, Inc.'s Free Cash Flow margin Good?

As of today, Regeneron Pharmaceuticals, Inc.'s Free Cash Flow margin is 25.3%, which is higher than industry median of (735.0%). It indicates that Regeneron Pharmaceuticals, Inc.'s Free Cash Flow margin is Good.

3) How does Regeneron Pharmaceuticals, Inc.'s Free Cash Flow margin compare to its peers?

As of today, Regeneron Pharmaceuticals, Inc.'s Free Cash Flow margin is 25.3%, which is higher than peer median of 14.8%. The list of peers includes SMMT, RPRX, UTHR, BNTX, NVO, INCY, ALNY, VRTX, ARGX, BGNE.